Clinical trials recruiting for Extrapulmonary Neuroendocrine Carcinoma (EP-NEC)
3
Recruiting trials
18
US states with sites
1
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 1 3Phase 2 2
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Atezolizumab | 1 |
| Carboplatin + Etoposide | 1 |
| Irinotecan (drug) | 1 |
| Lurbinectedin | 1 |
| ML261 | 1 |
| Paclitaxel | 1 |
| Peluntamig (PT217) | 1 |
| Topotecan | 1 |
| [212Pb]Pb-MP0712 | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Maryland | 2 |
| Missouri | 2 |
| New Jersey | 2 |
| Texas | 2 |
| California | 1 |
| Colorado | 1 |
| Connecticut | 1 |
| Georgia | 1 |
| Massachusetts | 1 |
| Nebraska | 1 |
| New York | 1 |
| North Carolina | 1 |
Top cities
St Louis, Missouri 2Atlanta, Georgia 1Baltimore, Maryland 1Boston, Massachusetts 1Chapel Hill, North Carolina 1Cleveland, Ohio 1Dallas, Texas 1Denver, Colorado 1Duarte, California 1Durham, North Carolina 1
Self-screener
Recruiting trials
- A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)
- A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
- Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors
Related conditions
Trials recruiting for Extrapulmonary Neuroendocrine Carcinoma (EP-NEC) often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Extrapulmonary Neuroendocrine Carcinoma (EP-NEC) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.